LivaNova

LivaNova, PLC is an American medical device manufacturer domiciled in the UK. The company develops devices used for cardiac surgery and neuromodulation. The company was formed in 2015 by a $2.7B merger between Houston, Texas-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. The company trades on the NASDAQ stock exchange under the ticker symbol "LIVN".
History.
Cyberonics, Inc. was founded in Houston, United States in 1987. Sorin, originally known as Sorin Biomedica and later Sorin Group, was founded in 1956 by Fiat and Montedison, Italy's two largest industrial groups at that time. The name is an acronym for Società Ricerche Impianti Nucleari (Company for Nuclear Plant Research). In March 2015, the companies announced they would be merging in a $2.7B transaction. The transaction closed and the company began trading under the new stock symbol on Oct. 19. 2015. In December 2017, LivaNova announced it would acquire Imthera Medical for approximately $224M. In 2018, LivaNova sold its cardiac rhythm management business unit to MicroPort for $190M. In 2020, LivaNova announced the sale of its heart valve (HV) business
Business units.
The new combined company announced in May 2015 that it was focused on three product categories and will operate as three business units. The three units are neuromodulation, with its operating HQ in Houston, cardiac surgery, with its operating HQ in Italy, cardiac rhythm management, with its operating HQ in France. In 2018 the cardiac rhythm management business unit was sold to focus on the remaining two. In March 2020, LivaNova established Epsy Health, a digital health unit aimed at empowering patients, caregivers and healthcare providers in their journey for the treatment of epilepsy. In December 2020, LivaNova announced the disposal of its heart valve (HV) business.